APA (7th ed.) Citation

WR, K., LE, T., & AP, C. (2022). Editorial: Risk of hepatocellular carcinoma with tenofovir vs entecavir-A "knock-out" is yet to be delivered-Authors' reply. Alimentary pharmacology & therapeutics, 55(10), 1344. https://doi.org/10.1111/apt.16920

Chicago Style (17th ed.) Citation

WR, Kim, Telep LE, and Chokkalingam AP. "Editorial: Risk of Hepatocellular Carcinoma with Tenofovir Vs Entecavir-A "Knock-out" Is yet to Be Delivered-Authors' Reply." Alimentary Pharmacology & Therapeutics 55, no. 10 (2022): 1344. https://doi.org/10.1111/apt.16920.

MLA (9th ed.) Citation

WR, Kim, et al. "Editorial: Risk of Hepatocellular Carcinoma with Tenofovir Vs Entecavir-A "Knock-out" Is yet to Be Delivered-Authors' Reply." Alimentary Pharmacology & Therapeutics, vol. 55, no. 10, 2022, p. 1344, https://doi.org/10.1111/apt.16920.